Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE

European Journal of Heart Failure

Volumn 7, Issue 6, 2005, Pages 1070-1075

  Cleland, John G F ^a   Coletta, Alison P ^a   Lammiman, Mike ^b   Witte, Klaus K ^c   Loh, Huan ^b   Nasir, Mansoor ^a   Clark, Andrew L ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

ACTIVE; CARE HF extension study; CIBIS III; ESSENTIAL; IMAGINE; ISSUE 2; PREAMI; S ICD; SIRIUS II; SOFA; STRIDE 2

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOTHELIN RECEPTOR ANTAGONIST; ENOXIMONE; IRBESARTAN; NESIRITIDE; OMEGA 3 FATTY ACID; PERINDOPRIL; QUINAPRIL; SITAXSENTAN; URODILATIN; WARFARIN; XIMELAGATRAN;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HUMAN; LIVER TOXICITY; META ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUBLICATION; PULMONARY HYPERTENSION; SYSTEMATIC REVIEW;

CARDIAC PACING, ARTIFICIAL; CARDIOLOGY; CONGRESSES; DEFIBRILLATORS, IMPLANTABLE; ENALAPRIL; ENOXIMONE; EUROPE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; ISOXAZOLES; MALE; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; SURVIVAL ANALYSIS; THIOPHENES; TREATMENT OUTCOME;

EID: 26644467896     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.09.006     Document Type: Article

References (22)

1. A.P. Coletta, J.G.F. Cleland, N. Freemantle, and A.L. Clark Clinical trials update from the European Society of Cardiology heart failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy Eur J Heart Fail 6 2004 673 676
2. J.G.F. Cleland, L.J. Kappenberger, L. Tavazzi, W. Klein, and E. Erdmann Design and methodology of the CARE-HF trial. A randomised trial of cardiac resynchronisation in patients with heart failure and ventricular dyssynchrony Eur J Heart Fail 3 2001 481 489
3. J.G.F. Cleland, J.C. Daubert, E. Erdmann on behalf of the CARE-HF study Steering Committee and Investigators. Baseline characteristics of patients recruited into the CARE-HF study Eur J Heart Fail 7 2005 205 214
4. J.G.F. Cleland, J.C. Daubert, E. Erdmann for the CARE-HF study Investigators The effect of cardiac resynchronisation on morbidity and mortality in heart failure N Eng J Med 352 2005 1539 1549
5. The CEA Registry. www.hsph.harvard.edu/cearegistry/.
6. S.F. Shakar, W.T. Abraham, and E.M. Gilbert Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure J Am Coll Cardiol 31 1998 1336 1340
7. B.D. Lowes, M. Higginbotham, L. Petrovich Enoximone Study Group Low-dose enoximone improves exercise capacity in chronic heart failure J Am Coll Cardiol 36 2000 501 508
8. K. Lalukota, J.G.F. Cleland, L. Ingle, A.L. Clark, and A.P. Coletta Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study, and RHYTHM-ICD Eur J Heart Fail 6 2004 953 955
9. B.F. Uretsky, M. Jessup, M.A. Konstam Enoximone Multicentre Trial Group Multicentre trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared to placebo Circulation 82 1990 774 780
10. R. Willenheimer, E. Erdmann, F. Follath on behalf of the CIBIS-III investigators Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III Eur J Heart Fail 6 2004 493 500
11. R. Willenheimer, D.J. van Veldhuisen, and B. Silke Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence. Results of the randomized cardiac insufficiency bisoprolol study (CIBIS) III Circulation 2005 [Electronic publication ahead of print]
12. M. Komajda, B. Lutiger, and H. Madeira Tolerability of carvedilol and ACE-inhibition in mild heart failure. Results of CARMEN (carvedilol ACE-inhibitor remodelling mild CHF evaluation) Eur J Heart Fail 6 2004 467 475
13. J.G. Cleland, K. Swedberg, and F. Follath The EuroHeart Failure survey programme: a survey on the quality of care among patients with heart failure in Europe: Part 1. Patient characteristics and diagnosis Eur Heart J 24 2003 442 463
14. H. Ooi, W.S. Colucci, and M.M. Givertz Endothelin mediates increased pulmonary vascular tone in patients with heart failure. Demonstration by direct intrapulmonary infusion of sitaxsentan Circulation 106 2002 1618 1621
15. J.G.F. Cleland, N. Freemantle, and G. Kaye Clinical trials update from the American College of cardiology meeting Ω-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PAD and DEFINITE Eur J Heart Fail 6 2004 109 115
16. L. Tavazzi, G. Tognoni, and M.G. Franzosi Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure Eur J Heart Fail 6 2004 635 641
17. R.J. Shelton, P. Velavan, and N.P. Nikitin Clinical trials update from the American Heart Association meeting: ACORN-CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, SCD-HeFT cost effectiveness study Eur J Heart Fail 7 2005 127 135
18. P. Svensson, U. deFaire, P. Sleight, S. Yusuf, and J. Ostergren Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE substudy Hypertension 38 2001 E28 E32
19. J.G. Cleland, I. Findlay, and S. Jafri The warfarin/aspirin study in heart failure (WASH) a randomised trial comparing antithrombotic strategies for patients with heart failure Am Heart J 148 2004 157 164
20. J.G. Cleland, J. Ghosh, N. Freemantle, G.C. Kaye, M. Nasir, and A.L. Clark Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure Eur J Heart Fail 6 2004 501 506
21. G.W. Albers, H.C. Diener, L. Frison for the SPORTF-V investigators Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomised trial JAMA 293 2005 690 698
22. S.B. Olsson on behalf of the SPORTIF III investigators Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial Lancet 362 2003 1691 1698